ALG6ALG6, alpha-1,3-glucosyltransferase
Autism Reports / Total Reports
0 / 2Rare Variants / Common Variants
1 / 0Aliases
ALG6, CDG1CAssociated Syndromes
-Chromosome Band
1p31.3Associated Disorders
ASDRelevance to Autism
Evaluation of the clinical data from 41 patients with congenital disorder of glycosylation, type Ic, mediated by ALG6 mutations (ALG6-CDG) found that behavioral problems or mood disorders occurred in 14 patients, with most of these 14 patients showing autistic features. Furthermore, five patients with ALG6-CDG were diagnosed with autism (Morava et al., 2016).
Molecular Function
This gene encodes a member of the ALG6/ALG8 glucosyltransferase family that catalyzes the addition of the first glucose residue to the growing lipid-linked oligosaccharide precursor of N-linked glycosylation. Mutations in this gene are associated with congenital disorder of glycosylation, type Ic (CDG1C; OMIM 603147), a multisystem disorder resulting in a wide variety of clinical features, including developmental delay, hypotonia, epilepsy, ataxia, and failure to thrive.
External Links
SFARI Genomic Platforms
Reports related to ALG6 (2 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Primary | ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies | Morava E , et al. (2016) | No | ASD or autistic features |
2 | Support | - | Brea-Fernández AJ et al. (2022) | No | - |
Rare Variants (1)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.998C>T | p.Ala333Val | missense_variant | Familial | Both parents | - | 35322241 | Brea-Fernández AJ et al. (2022) |
Common Variants
No common variants reported.
SFARI Gene score
Syndromic


Evaluation of the clinical data from 41 patients with congenital disorder of glycosylation, type Ic, mediated by ALG6 mutations (ALG6-CDG) found that behavioral problems or mood disorders occurred in 14 patients, with most of these 14 patients showing autistic features. Furthermore, five patients with ALG6-CDG were diagnosed with autism (Morava et al., 2016).
Score Delta: Score remained at S
criteria met
See SFARI Gene'scoring criteriaThe syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
10/1/2019

Score remained at S
New Scoring Scheme
Description
Evaluation of the clinical data from 41 patients with congenital disorder of glycosylation, type Ic, mediated by ALG6 mutations (ALG6-CDG) found that behavioral problems or mood disorders occurred in 14 patients, with most of these 14 patients showing autistic features. Furthermore, five patients with ALG6-CDG were diagnosed with autism (Morava et al., 2016).
Reports Added
[New Scoring Scheme]Krishnan Probability Score
Score 0.33273405408519
Ranking 24601/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.055367626172513
Ranking 8446/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.85320061993134
Ranking 3579/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.19927402212809
Ranking 4278/20870 scored genes
[Show Scoring Methodology]